Aryl-3,4-dihydropyrimidinones (DHPM), thiazolopyrimidines and related heteroaromatic compounds are important classes of N-containing fused heterocycles widely used as key building blocks for pharmaceutical agents due to a wide range of biological activities that include antimicrobial and antitumor properties[1-6]. As part of a program aimed at preparing new bioactive heterocycles, we designed and synthesized a series of thiazolopyrimidines and their 2-arylidene derivatives. The compounds were fully characterized by 1D- and 2D-NMR, high resolution ESI-MS/MS and single crystal X-ray diffraction analysis, which indicated a consistent Z configuration at the arylidene double bond. In addition, the ESI-MS fragmentation mechanisms for representatives of the DHPM, thiazolopyrimidine, and 2-arylidene-thiazolopyrimidine classes were elucidated. Studies are underway to assess the biological activities of the new compounds.
References.
- B. Kuppast, H. Fahmy, Eur. J. Med. Chem. 113 (2016) 198-213.
- P. Selvam, V. Karthick, P. V. Kumar, M. A. Ali, Drug Disc. Ther. 6 (2012) 198-204.
- B. Pan, R. Huang, L. Zheng, C. Chen, S. Han, D. Qu, M. Zhu, P. Wei, Eur. J. Med. Chem. 46 (2011) 819-824.
- A. Nehad, M. S.Nermien, M. M. Ashraf, M. M. Abdulla, Monatsh Chem. 138 (2007) 715-724.
- O. Kappe, W.M.F. Fabian, M.A. Semones, Tetrahedron 53 (1997) 2803-2816.
- S. Atwal, B.N. Swanson, S.E. Unger, D.M. Floyd, S. Moreland, A. Hedberg, B.C. O'Reilly, J. Med. Chem. 34 (1991) 806-811.